EUVIMEDEUVIMED entdecken
Crossref

Unique intestinal microflora and metabolic profile in different stages of hypertension reveal potential biomarkers for early diagnosis and prognosis

Yaren Yu, Jiayi Zhu, Ruixue Fu, Lina Guo, Tao Chen, Zhaoyan Xu, Jianyu Zhang, Wensheng Chen, Lushi Chen, Xili Yang

Journal of Medical Microbiology · 2024

DOI: 10.1099/jmm.0.001839 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Microbiology, 2024. Verfasst von Yaren Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First People's Hospital of Foshan, No. 81 Lingnan RD, Foshan 528000, PR China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Biomarkers, Hypertension, Early Diagnosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Special Found of Foshan Summit Plan, Medical Scientific Research Foundation of Guangdong Province China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hypertension is the most prevalent chronic disease and a major risk factor for cardiovascular and cerebrovascular diseases. Gap statement. However, there has been no substantial breakthrough in aetiology, new drug targets, and drug development of hypertension in recent 50 years. Research aim. Therefore, this study was to screen unique intestinal microbiome and serum metabolic biomarkers which can early diagnose and track the prognosis of hypertension patients in different periods, and analyse its underlying mechanisms and functions.

Methods

Four groups of stool and serum samples, including healthy controls (HCs), prehypertension (PHT), hypertension (HT), and hypertension-related complications (HTC), were collected. Microbial diversity assessed using 16S rRNA sequencing. The metabolites in serum samples were detected through LC-MS/MS analysis.

Results

The composition of gut microbiota in patients exhibited dissimilarities compared to that in healthy subjects, which was distinguished by Prevotella, Slackia , Enterococcus , Bifidobacterium, and Lactobacillales may be potential markers for tracking the progression of hypertension, and Bifidobacterium , Butyricimonas , Adlercreutzia , Faecalibacterium , Lactobacillus , Ruminococcus , Clostridium , and Acidaminococcus demonstrated diagnostic value. Meanwhile, tracking the dynamic changes of deoxycholic acid, 4-oxododecanedioic acid, and l -arginine can serve as biomarkers for early diagnosis, and investigation into the mechanism by which the intestinal microbiome influences the onset and progression of hypertension. In terms of pathogenesis, the findings revealed that Bifidobacterium may caused the changes of AST, indirect bilirubin, ALT, triglyceride and uric acid by affecting metabolites cis-7-hexadecenoic acid methyl ester and N1-acetylspermidine. Additionally, Coprococcus may cause changes in albumin through the influence of androsterone enanthate.

Conclusions

These findings highlight that the unique intestinal microbiome and serum metabolic profile in different periods of hypertension will provide valuable insight for timely diagnosis and prognosis tracking in hypertension patients with promising clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeBiomarkersHypertensionEarly DiagnosisMetabolomeFecesHumansMiddle AgedPrognosisMaleFemaleAdultRNA, Ribosomal, 16SBacteriaAgedTandem Mass SpectrometryCase-Control Studies

Stichwörter der Autor:innen

early diagnosisgut microbiotahypertensionhypertension-related complicationsmetabolites

Substanzen

BiomarkersRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Cardiology, The First People's Hospital of Foshan, No. 81 Lingnan RD, Foshan 528000, PR China.
  • Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, PR China.
  • Clinical Nutrition Department, Guangdong Provincial Hospital of Chinese Medicine, No. 111 Dade RD, Guangzhou 510030, PR China.
  • Research and Development Department, Guangdong Longsee Biomedical Corporation, No. 83 Ruihe RD, Guangzhou, Guangdong 510700, PR China.
  • Arrhythmia Department, Guangdong Provincial Hospital of Chinese Medicine, No. 111 Dade RD, Guangzhou 510030, PR China.
  • Health Medical Center, Department of Cardiology, The First People's Hospital of Foshan, No. 81 Lingnan RD, Foshan 528000, PR China.

Förderung

  • Special Found of Foshan Summit Plan
  • Medical Scientific Research Foundation of Guangdong Province China

Zitieren

APA

Yu, Y., Zhu, J., Fu, R., Guo, L., Chen, T., Xu, Z., Zhang, J., Chen, W., Chen, L., & Yang, X. (2024). Unique intestinal microflora and metabolic profile in different stages of hypertension reveal potential biomarkers for early diagnosis and prognosis. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.001839

Vancouver

Yu Y, Zhu J, Fu R, Guo L, Chen T, Xu Z, et al. Unique intestinal microflora and metabolic profile in different stages of hypertension reveal potential biomarkers for early diagnosis and prognosis. Journal of Medical Microbiology. 2024. doi:10.1099/jmm.0.001839

BibTeX
@article{Yu2024,
  author = {Yu, Yaren and Zhu, Jiayi and Fu, Ruixue and Guo, Lina and Chen, Tao and Xu, Zhaoyan and Zhang, Jianyu and Chen, Wensheng and Chen, Lushi and Yang, Xili},
  title = {Unique intestinal microflora and metabolic profile in different stages of hypertension reveal potential biomarkers for early diagnosis and prognosis},
  journal = {Journal of Medical Microbiology},
  year = {2024},
  doi = {10.1099/jmm.0.001839}
}
Kostenlos starten →